BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4399279)

  • 41. Poliovirus coat protein as the site of guanidine action.
    Korant BD
    Virology; 1977 Aug; 81(1):25-36. PubMed ID: 196400
    [No Abstract]   [Full Text] [Related]  

  • 42. The poliovirus replication machinery can escape inhibition by an antiviral drug that targets a host cell protein.
    Crotty S; Saleh MC; Gitlin L; Beske O; Andino R
    J Virol; 2004 Apr; 78(7):3378-86. PubMed ID: 15016860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. H1PVAT is a novel and potent early-stage inhibitor of poliovirus replication that targets VP1.
    Tijsma A; Thibaut HJ; Spieser SA; De Palma A; Koukni M; Rhoden E; Oberste S; Pürstinger G; Volny-Luraghi A; Martin J; Marchand A; Chaltin P; Neyts J; Leyssen P
    Antiviral Res; 2014 Oct; 110():1-9. PubMed ID: 25043639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The mechanism of guanidine inhibition of poliovirus growth in vitro.
    La Colla P; De Giuli C; Cioglia AM; Zuffardi O; Loddo B
    Life Sci II; 1970 Dec; 9(23):1351-8. PubMed ID: 4099578
    [No Abstract]   [Full Text] [Related]  

  • 45. Virus infection as a function of the host cell life cycle: replication of poliovirus RNA.
    Eremenko T; Benedetto A; Volpe P
    J Gen Virol; 1972 Jul; 16(1):61-8. PubMed ID: 4340284
    [No Abstract]   [Full Text] [Related]  

  • 46. Stimulation of restricted reproduction of EMC virus in HeLa cells by non-replicating poliovirus.
    Shirman GA; Maslova SV; Gavrilovskaya IN; Agol VI
    Virology; 1973 Jan; 51(1):1-10. PubMed ID: 4119353
    [No Abstract]   [Full Text] [Related]  

  • 47. [Inhibition of poliovirus synthesis by indole-3-acetic acid at the cellular level].
    Garcia-Gancedo A; Rico S; Vilas P
    Microbiol Esp; 1972; 25(2):69-80. PubMed ID: 4343344
    [No Abstract]   [Full Text] [Related]  

  • 48. Medicine: silencing viruses with RNA.
    Carmichael GG
    Nature; 2002 Jul; 418(6896):379-80. PubMed ID: 12140542
    [No Abstract]   [Full Text] [Related]  

  • 49. Analysis of specificity of antibodies contained in antiserum against poliovirus with mutants resistant to inhibitors in equine serum.
    Urasawa S; Urasawa T; Kanamitsu M
    J Immunol; 1974 Aug; 113(2):537-42. PubMed ID: 4367633
    [No Abstract]   [Full Text] [Related]  

  • 50. [Mutagenic and inactivating effect of hydroxylamine in treating infectious RNA and native poliomyelitis virus].
    Gendon IuZ
    Vopr Virusol; 1966; 11(6):724-9. PubMed ID: 4303759
    [No Abstract]   [Full Text] [Related]  

  • 51. Antiviral activity of scillarenin, a plant bufadienolide.
    Sato N; Muro T
    Jpn J Microbiol; 1974 Nov; 18(6):441-8. PubMed ID: 4375728
    [No Abstract]   [Full Text] [Related]  

  • 52. Inhibition of poliovirus replication by N-methylisatin-beta-4':4'-dibutylthiosemicarbazone.
    Pearson GD; Zimmerman EF
    Virology; 1969 Aug; 38(4):641-50. PubMed ID: 4308565
    [No Abstract]   [Full Text] [Related]  

  • 53. Poliovirus single-stranded RNA and double-stranded RNA: differential infectivity in enucleate cells.
    Detjen BM; Lucas J; Wimmer E
    J Virol; 1978 Sep; 27(3):582-6. PubMed ID: 212582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Studies of the activity of diphtheria toxin. I. Poliovirus replication in intoxicated HeLa cells.
    Duncan JL; Groman NB
    J Exp Med; 1967 Mar; 125(3):489-500. PubMed ID: 4289295
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse effect of thiadiazolylcarbamic acid esters on measles and polio viruses in Vero cells. Brief report.
    Mirchamsy H; Lalezari L; Kamaly M; Niloufari G; Rezvani N
    Arch Gesamte Virusforsch; 1970; 29(2):267-70. PubMed ID: 4316763
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro antiviral activity of four isothiazole derivatives against poliovirus type 1.
    Pinizzotto MR; Garozzo A; Guerrera F; Castro A; La Rosa MG; Furneri PM; Geremia E
    Antiviral Res; 1992 Jul; 19(1):29-41. PubMed ID: 1332598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of arildone and 3-methylquercetin as stabilizers of poliovirus.
    Rombaut B; Vrijsen R; Boeye A
    Antiviral Res; 1985; Suppl 1():67-73. PubMed ID: 3002268
    [No Abstract]   [Full Text] [Related]  

  • 58. Antiviral activity of polyinosinic-polycytidylic acid in the absence of cell-controlled RNA synthesis.
    Kjeldsberg E; Flikke M
    J Gen Virol; 1971 Feb; 10(2):147-54. PubMed ID: 4101769
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of interferon treatment on blockade of protein synthesis induced by poliovirus infection.
    Muñoz A; Carrasco L
    Eur J Biochem; 1983 Dec; 137(3):623-9. PubMed ID: 6198175
    [TBL] [Abstract][Full Text] [Related]  

  • 60. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.
    Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B
    Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.